NCT06060613
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06060613
Title Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Obsidian Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute (Melanoma) RECRUITING Los Angeles California 90025 United States Details
USC Norris Comprehensive Cancer Center (Melanoma/NSCLC) RECRUITING Los Angeles California 90033 United States Details
Stanford Cancer Institute (Melanoma/NSCLC) RECRUITING Stanford California 94305 United States Details
Orlando Health Cancer Institute (Melanoma/NSCLC) RECRUITING Orlando Florida 32806 United States Details
James Graham Brown Cancer Center (Melanoma/NSCLC) RECRUITING Louisville Kentucky 40202 United States Details
Memorial Sloan Kettering (Melanoma/NSCLC) RECRUITING New York New York 10065 United States Details
The Ohio State University RECRUITING Columbus Ohio 43210 United States Details
Allegheny Research Institute (Melanoma/NSCLC) RECRUITING Pittsburgh Pennsylvania 15224 United States Details
M.D. Anderson Cancer Center (Melanoma/NSCLC) RECRUITING Houston Texas 77030 United States Details
Melanoma Institute of Australia RECRUITING Wollstonecraft New South Wales 2065 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field